Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oncimmune (ONC) Regulatory News

Date Source Headline
14th Dec 2022 2:00 pm RNS Result of Capital Raising
9th Dec 2022 1:30 pm RNS Extension of Capital Raising
7th Dec 2022 2:00 pm RNS Proposed Placing and Subscription
4th Nov 2022 4:16 pm RNS Grant of Options and PDMR Dealing
21st Sep 2022 2:16 pm RNS PDMR Dealing
21st Sep 2022 7:00 am RNS Unaudited results for the 12 months to 31 May 2022
30th Aug 2022 3:53 pm RNS Revised Notice of Results
15th Aug 2022 2:06 pm RNS Holding(s) in Company
8th Aug 2022 11:55 am RNS Holding(s) in Company
15th Jul 2022 10:44 am RNS Holding(s) in Company
13th Jul 2022 7:00 am RNS Grant of Options and PDMR Dealing
8th Jul 2022 7:00 am RNS Board Changes and Trading Update
20th Jun 2022 2:19 pm RNS Holding(s) in Company
16th Jun 2022 9:59 am RNS Holding(s) in Company
7th Jun 2022 10:20 am RNS Holding(s) in Company
6th Jun 2022 9:30 am RNS Holding(s) in Company
1st Jun 2022 8:18 am RNS Holding(s) in Company
31st May 2022 12:41 pm RNS Holding(s) in Company
26th May 2022 9:57 am RNS Holding(s) in Company
23rd May 2022 4:27 pm RNS Holding(s) in Company
20th May 2022 12:11 pm RNS Holding(s) in Company
18th May 2022 11:46 am RNS Holding(s) in Company
5th May 2022 5:32 pm RNS Holding(s) in Company
3rd May 2022 6:10 pm RNS Holding(s) in Company
26th Apr 2022 4:26 pm RNS Holding(s) in Company
21st Apr 2022 7:00 am RNS Queen’s Award for Enterprise in Innovation 2022
14th Apr 2022 12:24 pm RNS Exercise of Options, PDMR Dealing and TVR
8th Apr 2022 7:00 am RNS Two further ImmunoINSIGHTS contracts signed
4th Apr 2022 2:43 pm RNS Holding(s) in Company
29th Mar 2022 4:46 pm RNS Exercise of Options, PDMR Dealing and TVR
18th Mar 2022 3:01 pm RNS Holding(s) in Company
16th Mar 2022 7:00 am RNS Block Listing Six Monthly Return
15th Mar 2022 7:00 am RNS Exercise of Warrants and Total Voting Rights
9th Mar 2022 4:08 pm RNS Holding(s) in Company
7th Mar 2022 2:10 pm RNS PDMR Dealing
7th Mar 2022 7:00 am RNS Follow-on contract to validate previous profiling
4th Mar 2022 7:00 am RNS ImmunoINSIGHTS contract signed with global pharma
1st Mar 2022 7:00 am RNS ImmunoINSIGHTS and Synexa partnership
28th Feb 2022 7:05 am RNS Interim Results
28th Feb 2022 7:00 am RNS Contract signed with Verily Life Sciences
FTSE 100 Latest
Value8,463.46
Change46.12